Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.
Identifieur interne : 001728 ( Main/Exploration ); précédent : 001727; suivant : 001729Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.
Auteurs : D. Fumagalli [Belgique] ; T R Wilson [États-Unis] ; R. Salgado [Belgique] ; X. Lu [États-Unis] ; J. Yu [États-Unis] ; C. O'Brien [États-Unis] ; K. Walter [États-Unis] ; L Y Huw [États-Unis] ; C. Criscitiello [Italie] ; I. Laios [Belgique] ; V. Jose [Belgique] ; D N Brown [Belgique] ; F. Rothé [Belgique] ; M. Maetens [Belgique] ; D. Zardavas [Belgique] ; P. Savas [Australie] ; D. Larsimont [Belgique] ; M J Piccart-Gebhart [Belgique] ; S. Michiels [France] ; M R Lackner [États-Unis] ; C. Sotiriou [Belgique] ; S. LoiSource :
- Annals of oncology : official journal of the European Society for Medical Oncology [ 1569-8041 ] ; 2016.
Abstract
Estrogen receptor-positive (ER+) breast cancers (BCs) constitute the most frequent BC subtype. The molecular landscape of ER+ relapsed disease is not well characterized. In this study, we aimed to describe the genomic evolution between primary (P) and matched metastatic (M) ER+ BCs after failure of adjuvant therapy.
DOI: 10.1093/annonc/mdw286
PubMed: 27672107
Affiliations:
- Australie, Belgique, France, Italie, États-Unis
- Californie, Lombardie, Région de Bruxelles-Capitale
- Bruxelles, Milan
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001730
- to stream PubMed, to step Curation: 001707
- to stream PubMed, to step Checkpoint: 001707
- to stream Ncbi, to step Merge: 003C15
- to stream Ncbi, to step Curation: 003C15
- to stream Ncbi, to step Checkpoint: 003C15
- to stream Main, to step Merge: 001723
- to stream Main, to step Curation: 001728
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.</title><author><name sortKey="Fumagalli, D" sort="Fumagalli, D" uniqKey="Fumagalli D" first="D" last="Fumagalli">D. Fumagalli</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Wilson, T R" sort="Wilson, T R" uniqKey="Wilson T" first="T R" last="Wilson">T R Wilson</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Salgado, R" sort="Salgado, R" uniqKey="Salgado R" first="R" last="Salgado">R. Salgado</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Lu, X" sort="Lu, X" uniqKey="Lu X" first="X" last="Lu">X. Lu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biostatistics, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Yu, J" sort="Yu, J" uniqKey="Yu J" first="J" last="Yu">J. Yu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biostatistics, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="O Brien, C" sort="O Brien, C" uniqKey="O Brien C" first="C" last="O'Brien">C. O'Brien</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Walter, K" sort="Walter, K" uniqKey="Walter K" first="K" last="Walter">K. Walter</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Huw, L Y" sort="Huw, L Y" uniqKey="Huw L" first="L Y" last="Huw">L Y Huw</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Criscitiello, C" sort="Criscitiello, C" uniqKey="Criscitiello C" first="C" last="Criscitiello">C. Criscitiello</name><affiliation wicri:level="3"><nlm:affiliation>Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Laios, I" sort="Laios, I" uniqKey="Laios I" first="I" last="Laios">I. Laios</name><affiliation wicri:level="3"><nlm:affiliation>Department of Pathology, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Pathology, Institut Jules Bordet, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Jose, V" sort="Jose, V" uniqKey="Jose V" first="V" last="Jose">V. Jose</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Brown, D N" sort="Brown, D N" uniqKey="Brown D" first="D N" last="Brown">D N Brown</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Rothe, F" sort="Rothe, F" uniqKey="Rothe F" first="F" last="Rothé">F. Rothé</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Maetens, M" sort="Maetens, M" uniqKey="Maetens M" first="M" last="Maetens">M. Maetens</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Zardavas, D" sort="Zardavas, D" uniqKey="Zardavas D" first="D" last="Zardavas">D. Zardavas</name><affiliation wicri:level="3"><nlm:affiliation>Breast International Group, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast International Group, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Savas, P" sort="Savas, P" uniqKey="Savas P" first="P" last="Savas">P. Savas</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Larsimont, D" sort="Larsimont, D" uniqKey="Larsimont D" first="D" last="Larsimont">D. Larsimont</name><affiliation wicri:level="3"><nlm:affiliation>Department of Pathology, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Pathology, Institut Jules Bordet, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Piccart Gebhart, M J" sort="Piccart Gebhart, M J" uniqKey="Piccart Gebhart M" first="M J" last="Piccart-Gebhart">M J Piccart-Gebhart</name><affiliation wicri:level="3"><nlm:affiliation>Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Division of Medical Oncology, Institut Jules Bordet, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Michiels, S" sort="Michiels, S" uniqKey="Michiels S" first="S" last="Michiels">S. Michiels</name><affiliation wicri:level="1"><nlm:affiliation>Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif</wicri:regionArea><wicri:noRegion>Villejuif</wicri:noRegion><wicri:noRegion>Villejuif</wicri:noRegion></affiliation></author><author><name sortKey="Lackner, M R" sort="Lackner, M R" uniqKey="Lackner M" first="M R" last="Lackner">M R Lackner</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Sotiriou, C" sort="Sotiriou, C" uniqKey="Sotiriou C" first="C" last="Sotiriou">C. Sotiriou</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Loi, S" sort="Loi, S" uniqKey="Loi S" first="S" last="Loi">S. Loi</name><affiliation><nlm:affiliation>Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia sherene.loi@petermac.org.</nlm:affiliation><wicri:noCountry code="subField">Australia sherene.loi@petermac.org.</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27672107</idno><idno type="pmid">27672107</idno><idno type="doi">10.1093/annonc/mdw286</idno><idno type="wicri:Area/PubMed/Corpus">001730</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001730</idno><idno type="wicri:Area/PubMed/Curation">001707</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001707</idno><idno type="wicri:Area/PubMed/Checkpoint">001707</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001707</idno><idno type="wicri:Area/Ncbi/Merge">003C15</idno><idno type="wicri:Area/Ncbi/Curation">003C15</idno><idno type="wicri:Area/Ncbi/Checkpoint">003C15</idno><idno type="wicri:Area/Main/Merge">001723</idno><idno type="wicri:Area/Main/Curation">001728</idno><idno type="wicri:Area/Main/Exploration">001728</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.</title><author><name sortKey="Fumagalli, D" sort="Fumagalli, D" uniqKey="Fumagalli D" first="D" last="Fumagalli">D. Fumagalli</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Wilson, T R" sort="Wilson, T R" uniqKey="Wilson T" first="T R" last="Wilson">T R Wilson</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Salgado, R" sort="Salgado, R" uniqKey="Salgado R" first="R" last="Salgado">R. Salgado</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Lu, X" sort="Lu, X" uniqKey="Lu X" first="X" last="Lu">X. Lu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biostatistics, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Yu, J" sort="Yu, J" uniqKey="Yu J" first="J" last="Yu">J. Yu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biostatistics, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="O Brien, C" sort="O Brien, C" uniqKey="O Brien C" first="C" last="O'Brien">C. O'Brien</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Walter, K" sort="Walter, K" uniqKey="Walter K" first="K" last="Walter">K. Walter</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Huw, L Y" sort="Huw, L Y" uniqKey="Huw L" first="L Y" last="Huw">L Y Huw</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Criscitiello, C" sort="Criscitiello, C" uniqKey="Criscitiello C" first="C" last="Criscitiello">C. Criscitiello</name><affiliation wicri:level="3"><nlm:affiliation>Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Laios, I" sort="Laios, I" uniqKey="Laios I" first="I" last="Laios">I. Laios</name><affiliation wicri:level="3"><nlm:affiliation>Department of Pathology, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Pathology, Institut Jules Bordet, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Jose, V" sort="Jose, V" uniqKey="Jose V" first="V" last="Jose">V. Jose</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Brown, D N" sort="Brown, D N" uniqKey="Brown D" first="D N" last="Brown">D N Brown</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Rothe, F" sort="Rothe, F" uniqKey="Rothe F" first="F" last="Rothé">F. Rothé</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Maetens, M" sort="Maetens, M" uniqKey="Maetens M" first="M" last="Maetens">M. Maetens</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Zardavas, D" sort="Zardavas, D" uniqKey="Zardavas D" first="D" last="Zardavas">D. Zardavas</name><affiliation wicri:level="3"><nlm:affiliation>Breast International Group, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast International Group, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Savas, P" sort="Savas, P" uniqKey="Savas P" first="P" last="Savas">P. Savas</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Larsimont, D" sort="Larsimont, D" uniqKey="Larsimont D" first="D" last="Larsimont">D. Larsimont</name><affiliation wicri:level="3"><nlm:affiliation>Department of Pathology, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Pathology, Institut Jules Bordet, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Piccart Gebhart, M J" sort="Piccart Gebhart, M J" uniqKey="Piccart Gebhart M" first="M J" last="Piccart-Gebhart">M J Piccart-Gebhart</name><affiliation wicri:level="3"><nlm:affiliation>Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Division of Medical Oncology, Institut Jules Bordet, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Michiels, S" sort="Michiels, S" uniqKey="Michiels S" first="S" last="Michiels">S. Michiels</name><affiliation wicri:level="1"><nlm:affiliation>Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif</wicri:regionArea><wicri:noRegion>Villejuif</wicri:noRegion><wicri:noRegion>Villejuif</wicri:noRegion></affiliation></author><author><name sortKey="Lackner, M R" sort="Lackner, M R" uniqKey="Lackner M" first="M R" last="Lackner">M R Lackner</name><affiliation wicri:level="2"><nlm:affiliation>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Oncology Biomarker Development, Genentech Inc., South San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Sotiriou, C" sort="Sotiriou, C" uniqKey="Sotiriou C" first="C" last="Sotiriou">C. Sotiriou</name><affiliation wicri:level="3"><nlm:affiliation>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Loi, S" sort="Loi, S" uniqKey="Loi S" first="S" last="Loi">S. Loi</name><affiliation><nlm:affiliation>Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia sherene.loi@petermac.org.</nlm:affiliation><wicri:noCountry code="subField">Australia sherene.loi@petermac.org.</wicri:noCountry></affiliation></author></analytic><series><title level="j">Annals of oncology : official journal of the European Society for Medical Oncology</title><idno type="eISSN">1569-8041</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Estrogen receptor-positive (ER+) breast cancers (BCs) constitute the most frequent BC subtype. The molecular landscape of ER+ relapsed disease is not well characterized. In this study, we aimed to describe the genomic evolution between primary (P) and matched metastatic (M) ER+ BCs after failure of adjuvant therapy.</div></front></TEI><affiliations><list><country><li>Australie</li><li>Belgique</li><li>France</li><li>Italie</li><li>États-Unis</li></country><region><li>Californie</li><li>Lombardie</li><li>Région de Bruxelles-Capitale</li></region><settlement><li>Bruxelles</li><li>Milan</li></settlement></list><tree><noCountry><name sortKey="Loi, S" sort="Loi, S" uniqKey="Loi S" first="S" last="Loi">S. Loi</name></noCountry><country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="Fumagalli, D" sort="Fumagalli, D" uniqKey="Fumagalli D" first="D" last="Fumagalli">D. Fumagalli</name></region><name sortKey="Brown, D N" sort="Brown, D N" uniqKey="Brown D" first="D N" last="Brown">D N Brown</name><name sortKey="Jose, V" sort="Jose, V" uniqKey="Jose V" first="V" last="Jose">V. Jose</name><name sortKey="Laios, I" sort="Laios, I" uniqKey="Laios I" first="I" last="Laios">I. Laios</name><name sortKey="Larsimont, D" sort="Larsimont, D" uniqKey="Larsimont D" first="D" last="Larsimont">D. Larsimont</name><name sortKey="Maetens, M" sort="Maetens, M" uniqKey="Maetens M" first="M" last="Maetens">M. Maetens</name><name sortKey="Piccart Gebhart, M J" sort="Piccart Gebhart, M J" uniqKey="Piccart Gebhart M" first="M J" last="Piccart-Gebhart">M J Piccart-Gebhart</name><name sortKey="Rothe, F" sort="Rothe, F" uniqKey="Rothe F" first="F" last="Rothé">F. Rothé</name><name sortKey="Salgado, R" sort="Salgado, R" uniqKey="Salgado R" first="R" last="Salgado">R. Salgado</name><name sortKey="Sotiriou, C" sort="Sotiriou, C" uniqKey="Sotiriou C" first="C" last="Sotiriou">C. Sotiriou</name><name sortKey="Zardavas, D" sort="Zardavas, D" uniqKey="Zardavas D" first="D" last="Zardavas">D. Zardavas</name></country><country name="États-Unis"><region name="Californie"><name sortKey="Wilson, T R" sort="Wilson, T R" uniqKey="Wilson T" first="T R" last="Wilson">T R Wilson</name></region><name sortKey="Huw, L Y" sort="Huw, L Y" uniqKey="Huw L" first="L Y" last="Huw">L Y Huw</name><name sortKey="Lackner, M R" sort="Lackner, M R" uniqKey="Lackner M" first="M R" last="Lackner">M R Lackner</name><name sortKey="Lu, X" sort="Lu, X" uniqKey="Lu X" first="X" last="Lu">X. Lu</name><name sortKey="O Brien, C" sort="O Brien, C" uniqKey="O Brien C" first="C" last="O'Brien">C. O'Brien</name><name sortKey="Walter, K" sort="Walter, K" uniqKey="Walter K" first="K" last="Walter">K. Walter</name><name sortKey="Yu, J" sort="Yu, J" uniqKey="Yu J" first="J" last="Yu">J. Yu</name></country><country name="Italie"><region name="Lombardie"><name sortKey="Criscitiello, C" sort="Criscitiello, C" uniqKey="Criscitiello C" first="C" last="Criscitiello">C. Criscitiello</name></region></country><country name="Australie"><noRegion><name sortKey="Savas, P" sort="Savas, P" uniqKey="Savas P" first="P" last="Savas">P. Savas</name></noRegion></country><country name="France"><noRegion><name sortKey="Michiels, S" sort="Michiels, S" uniqKey="Michiels S" first="S" last="Michiels">S. Michiels</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001728 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001728 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27672107
|texte= Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27672107" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |